Clinical utility of eslicarbazepine: current evidence - Zaccara, Gaetano; Giovannelli, Fabio; Cincotta, Massimo; Carelli, Alessia; Verrotti, Alberto (Drug design, development and therapy, 2015)
Keywords: Acetic acid; Affinity; Animals; Anticonvulsants - administration & dosage; Anticonvulsants - adverse effects; Anticonvulsants - therapeutic use; Antiepileptic agents; antiepileptic drugs; Carbamazepine; Children; Clinical trials; Convulsions & seizures; Deactivation; Dibenzazepines - administration & dosage; Dibenzazepines - adverse effects; Dibenzazepines - therapeutic use; Dosage and administration; Drug dosages; Drug metabolism; Drug resistance; Drug therapy; Epilepsy; Eslicarbazepine acetate; Esterases; Headache; Humans; Inactivation; Medical research; Mental disorders; Nausea; Neurological diseases; Oral administration; Oxcarbazepine; Patients; Pharmacology; pharmacoresistant epilepsy; Physiological aspects; Physiology; Plasma proteins; Review; Seizures; Seizures - diagnosis; Seizures - drug therapy; Sodium; Sodium channels (voltage-gated); Trade names; Vertigo; Vomiting; United States--US; Italy; epilepsy; antiepileptic drugs; eslicarbazepine acetate; oxcarbazepine; pharmacoresistant epilepsy; carbamazepine